UBS Am, A Distinct Business Unit of UBS Asset Management Americas 13F: Adds $36M to ALAB Stake

UBS Am boosted its position in Astera Labs, Inc. during the period, adding tens of thousands of shares to its portfolio.

Reviewed by automated data checks against the source filing. How we make and check alerts

UBS Am, A Distinct Business Unit of UBS Asset Management Americas added 72,910 shares to its stake in Astera Labs, Inc. ($ALAB), a 12.65% increase, according to a 13F filing with the SEC dated May 13, 2026. It reported 649,191 shares worth $320.96 million at the end of the quarter.

Since the filing, $ALAB is up 28.3% after 1 week, up 63.8% after 1 month and up 27.6% to date (from the $224.09 close on May 13, 2026).

Find the original: UBS Am, A Distinct Business Unit of UBS Asset Management Americas 13F filings on SEC EDGAR

ALAB Astera Labs, Inc.
$285.82 +59.18% year to date
Daily close · Oct 16, 2026

Key Points

  • UBS Am boosted its stake in Astera Labs, Inc. (NasdaqGS: ALAB) by 12.7%, adding 72,910 shares during the reporting period.
  • The institutional investor's holding reached 649,191 shares with a reported value of roughly $320.9 million based on the latest SEC filing.
  • Astera Labs shares recently traded near $494.40, resting well above their 50-day and 200-day moving averages.

Get $ALAB trade alerts by text

We text you when insiders, Congress or big funds trade $ALAB. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Astera Labs, Inc. alert may contain errors. Disclosures

UBS Am Grows Position in Astera Labs, Inc.

UBS Am, A Distinct Business Unit of UBS Asset Management Americas expanded its holdings in Astera Labs, Inc. (NasdaqGS: ALAB) during the period, according to a Form 13F filing submitted to the Securities and Exchange Commission. The filing reflects holdings as of the reporting period and may not represent the investor's current position.

13F track record

UBS Am, A Distinct Business Unit of UBS Asset Management Americas vs. the S&P 500

YTD return +16.21% hypothetical
All-time return +117.53% S&P 500 +85.59%
vs. S&P 500 +31.94% ahead of the index

Hypothetical returns from UBS Am, A Distinct Business Unit of UBS Asset Management Americas's disclosed trades, not real profit or advice. How we model this.

Portfolio Move Adds Over 72,000 Shares

During the period, UBS Am lifted its position by a 12.7% increase, purchasing an additional 72,910 shares. That pushed its total holdings to 649,191 shares. The value of the fund's stake came out to approximately $320.9 million at the close of the reporting window.

Astera Labs Stock Trades Near Highs

Shares of Astera Labs changed hands around $494.40 on Wednesday. The company's stock has traded near the upper end of its 52-week range, which spans from a low of $97.89 to a high of $499.48. Its 50-day moving average sits at $316.57 while the 200-day moving average is $248.58.

Insider Buying and Selling at Astera Labs, Inc.

In recent insider transactions, insider Bethany Mayer completed a planned sale of 686 shares on June 24, 2026. The shares were sold at an average price of $395.04 for a total transaction value of $270,998.67 under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Firms Update Outlooks

Wall Street firms have continued updating their outlooks on the semiconductor firm. On August 17, 2026, Northland Capital Markets upgraded the stock to an Outperform rating with a $350.00 price target. Earlier in August, RBC Capital maintained an Outperform rating while raising its price target to $500.00, and Evercore ISI Group maintained an Outperform rating with a target of $452.00.

Inside Astera Labs Operations

Astera Labs designs and builds semiconductor-based connectivity hardware and software for cloud and artificial intelligence data centers. The company sells specialized products that help move data quickly between advanced processors and memory modules inside massive server networks. These systems are used by major cloud providers to keep large hardware clusters running smoothly.

What to Watch at Astera Labs, Inc.

The company is scheduled to report its next round of earnings on November 3, 2026. Investors tracking institutional interest will need to wait for subsequent quarterly filings to see whether UBS Am and other large asset managers continue adjusting their positions.

Source: UBS Am, A Distinct Business Unit of UBS Asset Management Americas's 13F filing on $ALAB (May 13, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: UBS Am, A Distinct Business Unit of UBS Asset Management Americas 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $ALAB trade alerts by text